Market Trends of United Kingdom Drug Delivery Devices Industry
This section covers the major market trends shaping the UK Drug Delivery Devices Market according to our research experts:
Topical Drug Delivery Devices is Estimated to Witness a Healthy Growth in Future.
- Topical drug delivery devices are estimated to witness healthy growth in the future due to several benefits associated with this type of route of administration, such as ease of use, painless and noninvasive delivery, convenience, and superior spreadability. In addition, the rising prevalence of skin diseases and improved patient compliance are expected to support market growth.
- For instance, according to the World Health Organization (WHO) statistics updated in May 2021, every year, around two million people are diagnosed with non-melanoma skin cancers and 132,000 with melanoma, and the frequency of the disease continues to rise. The main cause of increased skin cancer rates is ozone depletion, which means more harmful UV radiation reaches the earth's surface. WHO estimates that a 10% decline in ozone levels leads to an additional 300,000 instances of skin cancer. Thus, the growing prevalence of skin diseases is expected to propel the segment's growth over the forecast period.
- In addition, with the advent of novel drug delivery systems, topical drug delivery systems have recently gained pace. With the help of modern mathematical models, sophisticated instrumentation, and computational power, the formulation process has been revolutionized by the advancement of topical drug delivery systems.
- For instance, in September 2021, Almirall launched Klisyri (tirbanibulin), a brand-new, first-in-class topical microtubule inhibitor in Europe for managing actinic keratosis. The United Kingdom and Germany are the first European countries where Klisyri can be available on prescription.
- Additionally, in September 2021, Pfizer received marketing approval from the UK drug regulators for Cibinqo (abrocitinib), an oral JAK inhibitor cream for treating mild to moderate atopic dermatitis in patients aged 12 years. Thus, all factors mentioned above are expected to boost segment growth.
Understand The Key Trends Shaping This Market
Download PDF
Infectious diseases is Expected to Hold a Significant Market Share Over the Forecast Period
- Infectious diseases are illnesses caused by organisms like bacteria, viruses, fungi, or parasites. Some common communicable (infectious) diseases in the UK include measles, mumps, rubella, meningococcal, chicken pox, whooping cough, tuberculosis, scarlet fever, flu, and the common cold.
- The drug delivery devices segment is driven by the increasing prevalence of infectious diseases and product launches by the market players.
- As per the report published by the UK Health Security Agency (UKHSA) in December 2021, an estimated 97,740 people were living with HIV in England in 2020, and approximately 4,660 were unaware of their infection. The high burden of HIV in the country is expected to increase the demand for its therapeutics consumption, thereby driving the drug delivery devices market.
- Moreover, product launches in the market are further expected to impact the market growth positively. For instance, in June 2021, Glenmark Pharmaceuticals Ltd launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tiogiva in the country to treat chronic obstructive pulmonary disease (COPD).
- Furthermore, increasing research and development activities to produce sustainable drug delivery methods for COVID-19 vaccines will likely drive market growth.
- For instance, in December 2021, researchers at the University of Cambridge started a clinical trial on a needle-free, air-powered vaccination. This vaccine is intended to help fight COVID-19 variations in the future. The next-generation coronavirus vaccine, developed at the University of Cambridge and spin-out business DIOSynVax, is delivered through a blast of air that penetrates the skin. Such research activities boosting innovation are also likely to contribute to the market growth over the forecast period.
- Thus, all aforementioned factors, such as the increasing burden of infectious diseases and strategic initiatives by market players, are expected to boost the market over the forecast period.
